. . . . . . . . . . . . "[The MxA promoter with haplotype -88T/-123A confers greater expression of MxA in vitro, as well as a better treatment outcome for chronic hepatitis C patients treated with interferon in vivo, as compared to the MxA promoter with haplotype -88G/-123C.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2009-03-31"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:33:12+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .